Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2017

View Archived Issues

Opiant receives FDA feedback on development of OPNT-002 for alcohol use disorder

Novel fixed dose combination EHCV shows promise against chronic hepatitis C in clinical study

Amgen reports overall survival data from ENDEAVOUR study of Kyprolis

GS-PI-1 is a promising new generation HIV PI with favorable potency and resistance barrier

Promising results from the BCN02-Romi study of MVA.HIVconsv vaccine

Invenra and QIMR Berghofer collaborate to discover therapeutic antibodies

Bristol-Myers Squibb announces investment and plans for collaboration with Grail

EMA grants PRIME access to givosiran for acute hepatic porphyrias

European Commission approves Vihuma

European Commission grants orphan drug designation to apatinib for gastric cancer

Audentes initiates LUSTRO study in Crigler-Najjar syndrome

Pivotal Phase III study results for Merck & Co.'s varicella zoster virus vaccine presented

Arrakis Therapeutics completes Series A financing

SB-913 from Sangamo Therapeutics granted U.S. orphan drug designation for the treatment of MPS II

Boehringer Ingelheim's BI-836858 given U.S. orphan drug designation for the treatment of MDS

Sellas reports updated phase II data on galinpepimut-S in multiple myeloma

European Commission grants orphan drug designation to ZX-008 for Lennox-Gastaut syndrome

FDA grants priority review to enasidenib NDA

Pfizer and iTeos Therapeutics identify tryptophan 2,3-dioxygenase inhibitors

Eli Lilly completes acquisition of CoLucid Pharmaceuticals

Hetero Research Foundation discloses novel antiviral agents

FDA allows PR-022 to proceed to phase II study for the treatment of atopic dermatitis

Myovant initiates phase III trial of relugolix for advanced prostate cancer

Toray Industries initiates first-in-human study of TRK-950 in advanced solid tumors

Intensity Therapeutics studies intratumorally dosed INT-230-6 in advanced cancers

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...